Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Aptus Pharma Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 245.58 |
| Expenses | N/A | N/A |
| PBT | N/A | 41.95 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 31.0 |
About Aptus Pharma Ltd.
| Founded | 2010 |
|---|---|
| Managing Director | Tejash Maheshchandra Hathi |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Adani Enterprises Ltd. | 3,26,952.86 | 2,511.75 | 1,753.00 - 1,753.00 |
| Premier Energies Ltd. | 46,207.72 | 1,017.90 | 660.00 - 660.00 |
| Aditya Infotech Ltd. | 29,057.25 | 2,466.70 | 0.00 - 0.00 |
| Aegis Logistics Ltd. | 25,954.70 | 738.00 | 576.10 - 576.10 |
| Redington Ltd. | 17,550.84 | 224.50 | 191.31 - 191.31 |
| Honasa Consumer Ltd. | 11,529.48 | 354.00 | 237.00 - 237.00 |
| Lloyds Enterprises Ltd. | 10,681.28 | 69.97 | 40.69 - 40.69 |
| MMTC Ltd. | 10,015.50 | 66.98 | 50.10 - 50.10 |
| Cello World Ltd. | 9,333.50 | 424.50 | 382.55 - 382.55 |
| Jeena Sikho Lifecare Ltd. | 9,180.23 | 740.00 | 376.00 - 376.00 |
No Records Found
Latest News
Aptus Pharma informs about board meeting
Pursuant to Regulation 29(1)(a) read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aptus Pharma has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 27th April, 2026, to consider and approve the audited Financial Results of the Company for the half year/Year ended 31st March, 2026 and to take on record the Auditor Report thereon. Further, in accordance with the Company's Code of Conduct for Prohibition of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Company’s securities has been closed and shall remain closed till 48 hours after the declaration of the said financial results.
The above information is a part of company’s filings submitted to BSE.
Sirca Paints India informs about analyst meet
Bizotic Commercial informs about outcome of board meeting
Parshva Enterprises informs about newspaper publication
AVI Polymers informs about outcome of board meeting
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Aptus Pharma Ltd. is ₹445.00 as of 2026-05-07.
The market capitalisation of Aptus Pharma Ltd. is ₹305.27 as of 2026-05-07.
The 1-year return of Aptus Pharma Ltd. is % as of .
The P/E ratio of Aptus Pharma Ltd. is 0.00 as of 2026-05-08.
The 52-week high and low of Aptus Pharma Ltd. are ₹446.80 and ₹80.80, respectively, as of 2026-05-07.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
